Articles

Hilbert mansion to be auctioned

CNO Financial Group Inc. will resort to a sealed-bid auction to unload the lavish Hilbert mansion in Carmel, which has been
on the market for five years. Its latest asking price was $9.9 million.

Read More

Health reform rule could cost WellPoint

WellPoint Inc. has about $800 million riding on one arcane rule: how to calculate a medical loss ratio. The ratio quantifies
the percentage of customers’ premiums were spent on medical care, rather than overhead or profits.

Read More

Connecticut to probe WellPoint security breach

Attorney general seeks more details on the breach, which may have compromised financial and health information on almost 500,000
people. He also calls on the Indianapolis-based insurer to provide affected customers with credit monitoring and theft protection
services.

Read More

Security glitch exposes WellPoint customer data

Indianapolis-based WellPoint Inc. says it notified 470,000 individual insurance customers about an online security breach
that may have exposed medical records, credit card numbers and other sensitive information.

Read More

OneAmerica to acquire McCready and Keene

McCready and Keene Inc. is the fifth-largest employee benefits firm in the Indianapolis area. It employs 95 people nationally, 82 of them in Indianapolis, according to IBJ research.

Read More

Indy firm launches bedsore weapon

The latest idea from Dr. James Spahn, an Indianapolis health care entrepreneur, should help hospitals and nursing homes do
a better job of preventing severe bedsores, or pressure ulcers. That’s good, because Medicare and private health insurers
increasingly won’t pay to treat them.

Read More

Effective stats are new hurdle for U.S. drugmakers

WellPoint Inc.'s announcement of comparative effectiveness research guidelines last week marks a new era for U.S. drugmakers.
The Indianapolis-based health insurer will use studies that compare the effectiveness of one drug against another as a complement
to typical clinical trial research that compares a drug against a placebo sugar pill.

Read More